United States

Peregrine Pharmaceuticals Inc (PPHM.OQ)

PPHM.OQ on NASDAQ Stock Exchange Capital Market

4:00pm EDT
Change (% chg)

$-0.00 (-0.57%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Mon, Apr 17 2017

BRIEF-Ronin Capital LLC reports 5.8 pct stake in Peregrine Pharmaceuticals

* Ronin Capital LLC reports 5.8 percent stake in Peregrine Pharmaceuticals Inc as of April 6 - sec filing Source text : http://bit.ly/2prmM8N Further company coverage:

BRIEF-Peregrine Pharma presents data for Bavituximab's anti-tumor enhancing activity

* Peregrine Pharmaceuticals highlights clinical data presentation at aacr 2017 annual meeting supporting potential of Bavituximab to enhance anti-tumor activity of immunotherapy

BRIEF-Peregrine Pharmaceuticals Q3 loss per share $0.04

* Sees FY 2017 revenue from avid bioservices business of $60 million-$65 million

BRIEF-Ronin Capital reports 6.8 pct stake in Peregrine pharma as of feb 21 - SEC filing

* As of feb 21 Ronin Capital Llc Reports 6.8 Pct Stake In Peregrine Pharmaceuticals Inc- SEC filing Source text for Eikon: [ID:http://bit.ly/2lyZfNi] Further company coverage:

Select another date:

More From Around the Web